ArticleJournal for immunotherapy of cancer2020

Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response.

Xiaoqiang Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.